DE60006663T2 - Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung - Google Patents
Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung Download PDFInfo
- Publication number
- DE60006663T2 DE60006663T2 DE60006663T DE60006663T DE60006663T2 DE 60006663 T2 DE60006663 T2 DE 60006663T2 DE 60006663 T DE60006663 T DE 60006663T DE 60006663 T DE60006663 T DE 60006663T DE 60006663 T2 DE60006663 T2 DE 60006663T2
- Authority
- DE
- Germany
- Prior art keywords
- dihydrate
- active
- production
- medicines
- contain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12949999 | 1999-05-11 | ||
PCT/JP2000/002952 WO2000068231A1 (fr) | 1999-05-11 | 2000-05-09 | Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60006663D1 DE60006663D1 (de) | 2003-12-24 |
DE60006663T2 true DE60006663T2 (de) | 2004-10-07 |
Family
ID=15011000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60006663T Expired - Lifetime DE60006663T2 (de) | 1999-05-11 | 2000-05-09 | Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung |
Country Status (12)
Country | Link |
---|---|
US (2) | US6660745B1 (de) |
EP (1) | EP1178046B1 (de) |
JP (1) | JP3956188B2 (de) |
KR (1) | KR100747106B1 (de) |
CN (1) | CN1160355C (de) |
AT (1) | ATE254616T1 (de) |
AU (1) | AU4319000A (de) |
CA (1) | CA2373015A1 (de) |
DE (1) | DE60006663T2 (de) |
ES (1) | ES2206227T3 (de) |
TW (1) | TW546298B (de) |
WO (1) | WO2000068231A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100540046B1 (ko) | 1997-11-12 | 2006-01-10 | 미쓰비시 가가꾸 가부시키가이샤 | 퓨린유도체 및 이를 유효성분으로 함유하는 의약 |
DE60006663T2 (de) | 1999-05-11 | 2004-10-07 | Mitsubishi Chem Corp | Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung |
US7772123B2 (en) * | 2008-06-06 | 2010-08-10 | Infineon Technologies Ag | Through substrate via semiconductor components |
JP2021035910A (ja) * | 2017-11-01 | 2021-03-04 | 大日本住友製薬株式会社 | 置換プリン化合物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862189A (en) | 1973-08-14 | 1975-01-21 | Warner Lambert Co | Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents |
US3936454A (en) | 1973-08-14 | 1976-02-03 | Warner-Lambert Company | 5-Amino-4-chloro-6-(substituted amino)-pyrimidines |
DE2413935A1 (de) | 1974-03-20 | 1975-10-16 | Schering Ag | 4-(polyalkoxy-phenyl)-2-pyrrolidone |
US4193926A (en) | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
US5124455A (en) | 1990-08-08 | 1992-06-23 | American Home Products Corporation | Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents |
IE71647B1 (en) | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
GB9210839D0 (en) | 1992-05-21 | 1992-07-08 | Smithkline Beecham Plc | Novel compounds |
IL107611A0 (en) | 1992-11-18 | 1994-02-27 | Smithkline Beecham Corp | Steroid compounds and pharmaceutical compositions containing them |
BR9307570A (pt) | 1992-12-02 | 1999-05-25 | Pfizer | Diéteres de catecol como inibidores seletivos de pdeiv |
TW263495B (de) | 1992-12-23 | 1995-11-21 | Celltech Ltd | |
GB9312853D0 (en) | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
US5380838A (en) | 1993-10-08 | 1995-01-10 | Merck & Co. Inc. | Stable solvates of avermectin compounds |
NZ279030A (en) | 1994-01-07 | 1997-05-26 | Merrell Pharma Inc | 2'-deoxy-2'-(fluoromethylene)cytidine |
GB9420503D0 (en) | 1994-10-11 | 1994-11-23 | Pfizer Ltd | Therapeutic agents |
US5948913A (en) | 1994-11-14 | 1999-09-07 | Daiichi Pharmaceutical Co., Ltd. | Hydrate for drug use |
DE19501482A1 (de) | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,9-disubstituierte Purin-6-one |
GB9503717D0 (en) | 1995-02-24 | 1995-04-12 | Smithkline Beecham Plc | Novel compounds |
US5580977A (en) | 1995-03-01 | 1996-12-03 | Eli Lilly And Company | Process for preparing loracarbef monohydrate |
SE9501808D0 (sv) | 1995-05-16 | 1995-05-16 | Astra Ab | New process |
US5948931A (en) | 1996-07-12 | 1999-09-07 | University Of Southern California | Preparation and use of α-(hydroxyimino) phosphonoacetic acids |
KR100540046B1 (ko) | 1997-11-12 | 2006-01-10 | 미쓰비시 가가꾸 가부시키가이샤 | 퓨린유도체 및 이를 유효성분으로 함유하는 의약 |
DE60006663T2 (de) | 1999-05-11 | 2004-10-07 | Mitsubishi Chem Corp | Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung |
-
2000
- 2000-05-09 DE DE60006663T patent/DE60006663T2/de not_active Expired - Lifetime
- 2000-05-09 AU AU43190/00A patent/AU4319000A/en not_active Abandoned
- 2000-05-09 ES ES00923000T patent/ES2206227T3/es not_active Expired - Lifetime
- 2000-05-09 AT AT00923000T patent/ATE254616T1/de not_active IP Right Cessation
- 2000-05-09 JP JP2000616205A patent/JP3956188B2/ja not_active Expired - Fee Related
- 2000-05-09 CA CA002373015A patent/CA2373015A1/en not_active Abandoned
- 2000-05-09 EP EP00923000A patent/EP1178046B1/de not_active Expired - Lifetime
- 2000-05-09 WO PCT/JP2000/002952 patent/WO2000068231A1/ja active IP Right Grant
- 2000-05-09 CN CNB008073996A patent/CN1160355C/zh not_active Expired - Fee Related
- 2000-05-09 US US09/926,477 patent/US6660745B1/en not_active Expired - Fee Related
- 2000-05-09 KR KR1020017014295A patent/KR100747106B1/ko not_active IP Right Cessation
- 2000-05-10 TW TW089108951A patent/TW546298B/zh not_active IP Right Cessation
-
2003
- 2003-08-01 US US10/631,795 patent/US6919455B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20040077665A1 (en) | 2004-04-22 |
ES2206227T3 (es) | 2004-05-16 |
US6919455B2 (en) | 2005-07-19 |
WO2000068231A1 (fr) | 2000-11-16 |
CN1350535A (zh) | 2002-05-22 |
EP1178046A4 (de) | 2002-06-05 |
KR100747106B1 (ko) | 2007-08-08 |
ATE254616T1 (de) | 2003-12-15 |
AU4319000A (en) | 2000-11-21 |
US6660745B1 (en) | 2003-12-09 |
JP3956188B2 (ja) | 2007-08-08 |
CN1160355C (zh) | 2004-08-04 |
DE60006663D1 (de) | 2003-12-24 |
EP1178046B1 (de) | 2003-11-19 |
TW546298B (en) | 2003-08-11 |
EP1178046A1 (de) | 2002-02-06 |
KR20020015039A (ko) | 2002-02-27 |
CA2373015A1 (en) | 2000-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995006D0 (no) | Nye forbindelser | |
ATE197038T1 (de) | N-aroyl-glycin-hydroxamsäure-derivate und verwandte verbindungen | |
IT1254317B (it) | Perfezionato impiego di medicinali broncodilatatori b2. | |
BRPI0409427A (pt) | composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo | |
GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
DK0705265T3 (da) | Hidtil ukendte kemiske forbindelse med PDE IV-inhiberende aktivitet | |
BRPI0409314A (pt) | derivados de 2-aminopirimidina e seu uso médico | |
WO2006067445A3 (en) | Csf-1r kinase inhibitors | |
FI942075A0 (fi) | Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina | |
DE60317562D1 (de) | Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon | |
WO2007046868A3 (en) | Thiazolidine derivatives and their uses as therapeutic agents | |
EP1202735B1 (de) | Die Verwendung eines Benzimidazoles zur Herstellung eines Medikamentes zur Krebsvorbeugung | |
BRPI0518785A2 (pt) | composto de anel de 7 membros e mÉtodo de produÇço e aplicaÇço farmacÊutica do mesmo | |
ATE299143T1 (de) | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
BRPI0408727A (pt) | composto, processo para preparar o mesmo, composição farmacêutica, método para tratar de uma condição ou estado de doença mediados pela atividade da quinase p38 ou mediados pelas citocinas produzidas pela atividade da quinase p38, e, uso de um composto | |
DE602004014163D1 (de) | Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken | |
WO2003087049A3 (de) | Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum | |
IL163951A0 (en) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
WO2006125194A3 (en) | Piperazine derivatives and their uses as therapeutic agents | |
AR034223A1 (es) | Novedosa indicacion terapeutica de azitromicina para el tratamiento de enfermedades inflamatorias no infecciosas | |
PT1124841E (pt) | Fenil-alcenoil-guanidinas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como composicao farmaceutica que as contem | |
WO1999012933A3 (en) | Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase | |
NO20055518L (no) | 5-hydroksyindoler med N-oksidgrupper, anvendelse derav som fosfodiesterase 4-inhibitor | |
DE60006663T2 (de) | Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |